Achilles Therapeutics plc - SPONSORED ADS (ACHL)

Historical Portfolio Holders from Q1 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / SPONSORED ADS
Shares, excl. options Q1 2024
23.5 M
Holdings value Q1 2024
$29.4 M
Value change Q1 2024
+$2.65 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
30
Number of buys Q1 2024
17
Number of sells Q1 2024
-9
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
00449L102
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 23.5 M $29.4 M +$2.65 M $1.25 30
2023 Q4 21.8 M $19.4 M -$318 K $0.89 18
2023 Q3 19.7 M $17.9 M -$91.1 K $0.91 16
2023 Q2 19.8 M $18.7 M -$523 K $0.95 16
2023 Q1 20.2 M $19.4 M -$1.27 M $0.96 16
2022 Q4 21.7 M $19.5 M -$7.99 M $0.90 21
2022 Q3 27.3 M $61.6 M +$232 K $2.26 23
2022 Q2 27.1 M $68.3 M +$1.41 M $2.52 21
2022 Q1 15.5 M $45.5 M -$4.27 M $2.94 20
2021 Q4 27.4 M $137 M -$13 M $5.01 28
2021 Q3 17.6 M $137 M -$11.4 M $7.79 19
2021 Q2 18.8 M $184 M +$18.2 M $9.79 29
2021 Q1 16.8 M $278 M +$278 M $16.55 29